PRINCETON, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2019 financial results on Wednesday, February 19, 2020 prior to market open.  In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
The live call is accessible by dialing (800) 367-2403 and using the passcode 7727863.  A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com.A webcast replay of the call can be accessed through the Investor Relations homepage of Integra’s website at www.integralife.com.  A replay of the call will be available until February 24, 2020 by dialing (888) 203-1112 and using the passcode 7727863.About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™.  For the latest news and information about Integra and its brands, please visit www.integralife.com.Investor Relations:
Sravan Emany
Senior Vice President, Strategy, Treasury & Investor Relations
(609) 936-2488
[email protected]Michael Beaulieu
Director, Investor Relations
(609) 750-2827
[email protected] Media Contact:
Laurene Isip
Senior Director, Global Corporate Communications
(609) 750-7984
[email protected]
Bay Street News